BSE - SMEListed
Aptus Pharma Limited

Aptus Pharma Limited

Company website
Aptus Pharma Limited seeks to raise ₹18,60,000 crore — fresh issue ₹18,60,000 crore, OFS ₹0 crore. Total shares offered: 2000.
Subscribe between 23-09-2025 and 25-09-2025. Allotment is expected on 26-09-2025, with listing on 30-09-2025. Action tip: if you’re unsure, consider starting with a small allocation and review the company’s prospectus.
Start Date23-09-2025
End Date25-09-2025
Listing Date30-09-2025
Allotment Date26-09-2025
Current Price₹82
GMP₹4 (5.71%)
Lot Size2000 Shares
Subscription21.48 Times
Face Value₹10 per share
Listing atBSE
Issue Price₹65 - ₹70
Pre Issue₹50,00,000
Post Issue₹68,60,000
Issue Size₹18,60,000
(aggregating up to 13.02 Cr)
Fresh Issue₹18,60,000
(aggregating up to 13.02 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Aptus Pharma Limited is currently around ₹4 (5.71%). This indicates an estimated listing price of approximately ₹69 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.

Gmp Details

Last UpdatedIPO PriceGMPEstimated Listing Price
21 Nov 2025, 09:34
₹70
₹4
₹74 (5.71%)
26 Sep 2025, 05:16
₹70
₹4
₹74 (5.71%)
25 Sep 2025, 09:45
₹70
₹8
₹78 (11.43%)
23 Sep 2025, 05:20
₹70
₹7
₹77 (10.00%)
20 Sep 2025, 04:51
₹70
₹7
₹77 (10.00%)
18 Sep 2025, 11:38
₹70
₹0
₹70 (0.00%)
17 Sep 2025, 10:06
₹70
₹0
₹70 (0.00%)
16 Sep 2025, 06:50
₹70
₹0
₹70 (0.00%)

Financials overview In Crores

Here is a quick look at the recent financial performance of Aptus Pharma Limited . The numbers below ( In Crores ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.

Key Performance

KPIMar-25Mar-24Mar-23
EPS
6.37
5.32
1.3
ROE
44.50
45.18
20.06
ROCE
45.66
21.70
12.77
RONW
0
0
0
PRE IPO(PE)
11.29
0
0
POST IPO(PE)
15.49
0
0

Subscription Details (No. of Shares)

The below shows how many shares were subscribed by each investor category in the Aptus Pharma Limited IPO. These numbers help you understand where the demand is coming from – whether it’s retail investors, QIBs, or NIBs. Higher subscription usually indicates strong interest and confidence from the market.

Subscription Demand (in ₹ Crore)

CategoryOfferedDemandTimes
QIBs
₹2.46
3.01
1.22
FIIs
₹0
3.01
0.00
RETAIL
₹4.34
129.75
29.90
HNIs 2+
₹0.62
14.56
23.48
HNIs 10+
₹1.25
38.84
31.07
Total
₹8.67
186.16
21.47

Application Wise Breakup (Approx. no of Apps)

CategoryReservedAppliedTimes
QIB
0
2
0.00
NIB
0
629
0.00
RETAIL
155
4,608
29.73
HNIs(10L +)
30
323
10.77
HNIs (2-10L)
15
306
20.40
Total
200
5,237
26.18
The IPO reservation for Aptus Pharma Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.

IPO Reservation

CategoryShares OffersNo. of Shares
Anchor
28.39%
5,28,000
QIB
18.92%
3,52,000
HNI
14.30%
2,66,000
RETAIL
33.33%
6,20,000
Market Maker
5.05%
94,000
TOTAL
100.00%
18,60,000

Lot(s) Distribution

CategoryLot(s)QtyAmountReserved
Retail (Min)
2
4,000
₹2,80,000
0
sHNI
3
6,000
₹4,20,000
0
bHNI
8
16,000
₹11,20,000
0
Below you can find the official contact details of Aptus Pharma Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.

Company Details

Phone: +91 76004 27827
Address: Ashutosh Buildcon, Opp. Slok - 2, Nr. Harikrupa Logistic Park, Aslali, Ahmedabad, Daskroi, Ahmedabad, Gujarat, 382427

IPO Registrar

Name: Bigshare Services Private Limited
Phone: +91-22-6263 8200